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Abstract
Trauma is a worldwide problem, with severe and wide ranging
consequences for individuals and society as a whole. Hemorrhage
is a major contributor to the dilemma of traumatic injury and its
care. In this article we describe the international epidemiology of
traumatic injury, its causes and its consequences, and closely
examine the role played by hemorrhage in producing traumatic
morbidity and mortality. Emphasis is placed on defining situations
in which traditional methods of hemorrhage control often fail. We
then outline and discuss modern principles in the management of
traumatic hemorrhage and explore developing changes in these
areas. We conclude with a discussion of outcome measures for
the injured patient within the context of the epidemiology of
traumatic injury.
Introduction
Although it is often thought of as being composed of
individual events, traumatic injury is a pandemic disease –
one that affects every nation in the world without regard for
economic development, racial or religious predominance, or
political ideology. The disease is acute in onset but often
results in chronic, debilitating health problems that have
effects beyond the individual victims. There are identifiable
broad trends in the epidemiology of trauma within individual
countries and regions, but injury has an impact in every
community regardless of demographics [1]. Traumatic
hemorrhage accounts for much of the wide ranging
international impact of injury, causing a large proportion of
deaths and creating great morbidity in the injured.
Epidemiology
Every individual in the world is at risk for traumatic injury. The
etiologies of injury are as diverse as the lifestyles and
socioeconomic backgrounds of its victims, ranging from
interpersonal violence and terrorism to motor vehicle crashes
and occupational accidents. Worldwide, an estimated
5 million people died as a result of injury in 2000, with a
mortality rate of 83 per 100,000 of the population. Injury
represented 9% of worldwide deaths and 12% of the burden
of disease [2]. More than 90% of injury-related fatalities occur
in low- and middle-income nations. The highest mortality rates
from injury occur in the less wealthy nations in Eastern
Europe, with the lowest rates in North America, Western
Europe, China, Japan, and Australia [2]. Globally, road traffic
injuries result in 1.2 million deaths per year, with an additional
20–50 million injuries. They rank as the 11th leading cause of
death overall, accounting for 2.1% of all deaths worldwide
and 25% of injury-related deaths [2]. The majority of traffic
injuries and fatalities occur in low- to middle-income nations,
with some of the highest fatality rates found in European
nations [3]. Violence is a large contributor to injury-related
fatality as well, with 1.6 million deaths worldwide in 2000,
representing 16% of mortality from injury [2]. It is by far the
leading cause of death among those aged 15–44 years and
is much more prevalent in low- to middle-income countries
[4]. Self-inflicted violence represents 16% of injury-related
mortality worldwide, with falls and burns accounting for 6%
and 5%, respectively [2].
In the USA in 2001, where more than 10% of residents
suffered nonfatal injuries, trauma was the third leading cause
of death overall and was the leading cause of death among
those aged 1–44 years. There were 161,269 deaths from
injury in 2002, for an overall rate of 56 per 100,000
residents. Death from injury in the USA results in more years
of potential life lost before the age of 75 years than any other
cause, accounting for 23% of lost years and illustrating the
unequal burden of trauma on young people [5]. In Europe,
trauma disproportionately affects the young as well. For
example, nearly 40% of the injured in the German trauma
registry for 2002 were aged between 20 and 39 years, with
the greatest incidence occurring in persons aged between
20 and 24 years.
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Unintentional injuries account for the majority of trauma in all
age groups in the USA. Falls are the leading cause of
nonfatal injury in all age groups apart from those aged
15–24 years, and motor vehicle accidents cause the most
deaths from injury in all groups apart from infants and the
elderly. Although unintentional trauma predominates,
homicide is the second leading cause of death in US
residents aged 15–34 years, and these fatal injuries result
primarily from the use of firearms. In 2002 firearms caused
30,242 deaths for a rate of 10.5 per 100,000 residents.
Across all age groups, firearm suicide and homicide were the
third and fifth leading causes of overall injury or death,
respectively, in 2002 [5]. Firearms cause a smaller proportion
of traumatic injury in Europe than in the USA, and this is
reflected in lower rates of penetrating trauma. In the USA the
rate of penetrating trauma is around 20%, whereas in
Germany the rate is less than 5%.
Costs
Trauma carries with it a great price that is paid at all levels of
society – by individuals, families, communities, and nations.
The burden of traumatic injury ranges from the significant
financial costs of modern trauma care to the emotional
distress of having a loved one, especially a young individual,
become critically injured or die. The financial costs of road
traffic injuries alone can amount to up to 2% of a nation’s
gross national product [3]. The US Centers for Disease
Control and Prevention estimated that, in 2000, US$117
billion was spent on injury-attributable medical care,
amounting to approximately 10% of total US medical
expenditures [6]. In Germany, the cost of managing a multiply
injured patient can exceed €60,000 [7]. The actual economic
cost of injury is probably much higher, because the above
figures do not include the cost of life and work years lost
secondary to injury or death, the loss of property, and indirect
costs such as decreased quality of life and mental health
concerns. Many victims of trauma in the USA are among
those who are without health insurance, and much of the
economic cost of trauma care is either reimbursed directly by
public funds or is not reimbursed at all, with the cost deferred
in other billings. This places a disproportionate burden of the
financial costs of injury on taxpayers and on providers of
health care, and makes the provision of trauma care
financially unattractive to US health care institutions [1].
In addition to the economic cost of traumatic injury, a
considerable social burden is associated with it. Despite the
acuity of its onset, trauma often becomes a chronic disease
with significant long-term functional limitations and
decrements in quality of life. In one epidemiologic study [8]
22% of survivors of severe injury suffered permanent
disability and 57% had temporary disability. The life and work
years lost by the relatively young population of injury victims
has high associated costs in lost productivity and work years
[9,10]. The impact of the long-term care of trauma patients on
families and communities is an aspect of trauma care that
vastly increases the cost to society. The accumulated costs
of traumatic injury are large and not easily addressed at any
single level. Trauma prevention is doubtless the most
desirable way to decrease these burdens, and government
and private efforts are active in this effort but, as illustrated by
the statistics presented above, the problem remains. It is up
to those involved in the care of the injured patient to continue
striving for ways to optimize care and outcomes.
Epidemiology of traumatic fatality and
hemorrhage
The epidemiology of trauma mortality in the USA has been
investigated by a number of population-based studies over
the past quarter of a century [11-14]. These and other trauma
center-based studies [15,16] have provided a solid base of
literature in which to examine the characteristics of injury
patterns in the USA. The variety and quality of these
investigations allow conclusions to be drawn regarding the
epidemiology of traumatic fatality and the role of hemorrhage
and hemorrhagic shock.
Definitions
In order to appreciate fully the epidemiology of trauma and
injury, a clear understanding of definitions is necessary.
Epidemiologic studies of trauma refer commonly to the terms
‘cause of injury’ and ‘cause of death’. The former represents
the mechanism of bodily harm to the patient (gunshot wound,
motor vehicle crash, fall, etc.) but it does not account for the
injuries sustained or their severity. The cause of death, on the
other hand, is the result of the injuries sustained, and
represents the proximate event leading to the fatality.
Examples include hemorrhage, brain injury, and sepsis.
Epidemiologic studies tend to present causes (mechanisms)
of injury as being associated with fatality. This type of data
focuses efforts on preventing the occurrence of a particular
mechanism of injury. Although this is no doubt important,
measurable improvements in this area are small over time
[12]. As clinicians, those who care for trauma patients must
focus their efforts on the causes of traumatic death in order
to save lives.
Mechanism of injury
The proportions of various mechanisms of injury leading to
eventual fatality are somewhat inconsistent across
epidemiologic studies. In some analyses, penetrating injuries
such as gunshot or stab wounds account for as many as
49% of traumatic deaths, whereas in others blunt injuries
such as falls and motor vehicle crashes account for up to
60% of deaths [11,13,16]. Penetrating injuries tend to result
in earlier fatality, with most deaths occurring during the first
72 hours of hospital admission [11,15].
Cause of death
Even with these inconsistent proportions of fatal
mechanisms, the same analyses have all demonstrated that
injury to the central nervous system (particularly head injury)S3
is the leading overall cause of death in the lethally injured
patient, accounting for 40–50% of fatalities. Hemorrhage
following traumatic injury accounts for 30–40% of deaths
[13]. Fatal traumatic hemorrhage is primarily an acute
problem; one epidemiologic study [13] found that 36% of
patients who were found or declared dead at the scene of
injury had exsanguinated. Bleeding also accounts for a larger
share of mortality early on in trauma center admission, with
the majority of exsanguinations occurring during the first
48 hours [15]. This pattern implies an intuitive association
between penetrating mechanism and severe hemorrhage,
given the predominance of early fatality from penetrating
injuries.
Hemorrhagic shock
Hemorrhagic shock, in addition to directly resulting in early
fatality, is a predictor of poor outcome in the injured patient.
Early hypotension (systolic blood pressure = 90 mmHg) with
hemorrhage in the field or at initial hospital evaluation is
associated with complications such as eventual organ failure
and the development of infections, including sepsis [17,18].
In addition to the consequences of shock itself, the current
management of hemorrhagic shock in traumatic injury relies
heavily on transfusion of red blood cells (RBCs). These
transfusions are associated with the development of multiple
organ failure (MOF), increased intensive care unit (ICU)
admissions and length of stay, increased hospital length of
stay, and mortality [19-22].
As a critically injured patient progresses through the phases
of trauma care, death from causes unrelated to specific
injuries becomes more common. Infections such as sepsis
and pneumonia, systemic inflammatory response syndrome,
and MOF become the primary etiologies of traumatic death in
the hospitalized trauma patient [11,13,15].
Clinical aspects of traumatic hemorrhage
We have established that hemorrhage accounts for a
considerable amount of mortality and morbidity among injured
patients, and that most severe bleeding occurs during the
acute phase of injury, typically as a result of the injuries
sustained. We now examine the problem of traumatic
hemorrhage in detail, focusing on specific factors that place
injured patients at increased risk for severe bleeding and
situations in which traditional hemostatic methods may prove
inadequate.
Surgical bleeding
The hemorrhaging trauma patient frequently has injuries that
require urgent operation for control of bleeding, and more
than 80% of trauma deaths that occur in the operating room
do so as a result of hemorrhage [23]. These severe injuries
comprise a category known as ‘surgical bleeding’ and
account for about 50% of hypotensive patients. Surgical
bleeding is not a well defined term, but it can be described
broadly as including those injuries that can only be addressed
through direct operative visualization and controlled with
suture, packing, pressure, or application of a hemostatic
agent. If surgical bleeding is not controlled in this manner, it
will likely be fatal. Given the large proportion of operative
deaths secondary to hemorrhage, prevention of these
fatalities is clearly an area of potential improvement in the
care of the injured patient, and early intervention to control
bleeding is paramount.
Nonsurgical bleeding
Not all bleeding can or should be controlled surgically,
however, and there are various injuries and situations that fall
into the category of ‘nonsurgical bleeding’. These are areas in
which operative intervention has limited or no ability to control
hemorrhage, and in which attempts at surgical control have
the potential to exacerbate traumatic hemorrhage and lead to
severe bleeding and coagulopathy. Trauma care is constantly
evolving, and the trend is toward nonoperative management
of hemorrhage that was previously considered ‘surgical’ in
nature. Examples include hemorrhage from pelvic fractures,
which may be better addressed with angiographic
embolization than laparotomy; and coagulopathic bleeding,
which should be addressed by restoring normal hemostatic
physiology [24]. Operation for these problems can have
disastrous consequences, leading to further blood loss,
physiologic derangement, and possibly death. In addition,
some instances of intracranial bleeding, including certain
intracerebral and subdural hematomas, can be managed
nonoperatively [25-30]. Conservative, nonoperative manage-
ment of splenic and hepatic parenchymal bleeding without
operation is well described and studied, and is now standard
practice for all but the most severe injuries [24]. Keeping
patients with these problems out of the operating room
probably reduces morbidity and improves outcomes.
Medications
The injured patient may be predisposed to bleeding problems
over and above those occurring as a result of their injuries.
The use of medications that interfere with normal hemostatic
physiology is one area in which this is the case, and the use
of these medications is increasing. Warfarin and aspirin are
commonly used anticoagulants, and their use increases the
mortality rate from traumatic brain injuries by fourfold to
fivefold [31,32]. Clopidogrel is a commonly used antiplatelet
agent and has been shown to increase transfusion
requirements in cardiac surgery [33,34]. Ibuprofen, the
common nonsteroidal anti-inflammatory medication, is known
to interfere with platelet function, and its use has also been
shown to increase operative blood loss during hip surgery
[35]. Any of these medications may exacerbate bleeding
problems in trauma, although little research has been done in
this area.
Medical conditions
Previously existing medical conditions may also predispose a
trauma patient to bleeding problems. Patients with hemophilia
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and other inherited diseases have a tendency toward
spontaneous bleeding and to have unexpected hemorrhage
with minor trauma. These bleeding diatheses can dramatically
compound traumatic hemorrhage. In patients with cirrhosis,
failure of the liver to synthesize clotting factors results in
coagulopathy and poorer trauma outcomes, especially in the
operated patient [36,37]. Patients with renal insufficiency
often have platelet dysfunction resistant to platelet trans-
fusion [24]. Alcohol use, so common in trauma patients, is
also associated with platelet inhibition, although the effect
appears to be transient [38].
Acquired coagulopathy of trauma
The acquired coagulopathy of trauma is an important clinical
entity that is undergoing intensive study. The phenomenon is
responsible for the majority of postoperative traumatic
hemorrhagic fatalities, and the onset of an acute
coagulopathy is associated with increased overall mortality
[39-41]. The development of traumatic coagulopathy is
associated with massive transfusion and resuscitation,
increased injury severity, and the presence of hemorrhagic
shock [42,43]. The sequential and additive effects of the
‘lethal triad’ of hemodilution, hypothermia, and acidosis on the
coagulation cascade produce the ‘bloody vicious cycle’, and
unless intervention is performed to break this cycle it leads
rapidly to the demise of the injured patient from
coagulopathic exsanguinations [39,43-46]. Attempts to
interrupt the vicious cycle have resulted in the development of
modern methods of caring for the severely hemorrhaging
patient, including ‘damage control’ surgery, attention to
effective resuscitation and rewarming, and appropriate blood
and blood product transfusion. These management
techniques are discussed below.
Current management of traumatic hemorrhage
Prehospital care
The development of systematic, regionalized trauma care
occurred from the 1970s to the 1980s. In the USA and
across Europe, Latin America, Australia, and other developed
regions of the world, a number of structured systems exist at
regional, national, and local levels to manage prehospital
emergency care. A number of epidemiologic studies have
demonstrated remarkable improvements in patient survival
with the institution of these systematic approaches to
prehospital care in the USA and elsewhere [8,47-49]. These
systems are focused on trauma centers to which the most
severely injured patients are transported either directly from
the scene of injury or following stabilization at outlying
facilities within a geographic area. The provision of trauma
care is integrated from the level of the field emergency
service providers through outlying hospitals to the trauma
center. Rapid movement of patients from the scene of injury
to definitive trauma center care is geared toward providing
expeditious treatment of central nervous system injuries and
operative intervention for severe hemorrhage. Transport is
coordinated through a regional medical command, which
allows for appropriate triage, efficient communication
between care providers, and standardization of procedures.
The principal distinction that can be made between North
American (USA and Canada) prehospital care and that in
Europe is the proximity of the physician to the injured patient in
the field. In North American trauma systems, field care and
transport to hospital are performed nearly universally by
nonphysician emergency medical services personnel who
operate under the direction of a local medical director who is
trained in emergency medicine [50]. In Europe, the field of
prehospital trauma care has evolved differently, with more use
of physicians in the field in many countries. Patients are
triaged and treated at the scene of injury by the physician
responder and often directly admitted to the hospital for
definitive care. By virtue of these differences, field trauma care
in Europe tends to be more intensive, and the time to definitive
care can be shorter and initial triage more appropriate [51,52].
Phases of care
Despite the differences in prehospital care outlined above,
the acute management of traumatic hemorrhage is similar
around the world and follows well accepted published
guidelines [53,54]. In order to explore the management of
individual patients with traumatic hemorrhage, it is helpful to
define the chronology of a critically injured patient’s care as
occurring in three, often overlapping segments: the
resuscitative, operative, and critical care phases. The
diagnosis and control of bleeding should be a high priority
during all of the phases of trauma care and is especially
important in the patient who is in hemorrhagic shock. Early
attempts at hemorrhage control include direct control of
visible sources of severe bleeding with direct pressure,
pressure dressings, or tourniquets; stabilization of long bone
and pelvic fractures; and keeping the patient warm. Table 1
presents a summary of measures to enhance hemostasis
throughout the trauma patient’s treatment course.
Resuscitative phase
The resuscitative phase in the care of the hemorrhaging
patient begins in the field with the arrival of the first
responder. The patient’s airway is secured, respiration is
assured or provided, and a circulatory assessment is made. A
complete head-to-toe evaluation of the patient is undertaken
according to the principles of Prehospital Trauma Life
Support [53] and Advanced Trauma Life Support (ATLS)
[54], life-saving procedures are performed as necessary, and
transportation to a hospital is undertaken. Initial intravenous
fluid is administered during the resuscitative phase, and fluid
resuscitation can continue into and through the subsequent
operative phase. It is important to note that attempts to curtail
bleeding and prevent coagulopathy, and not just to normalize
the patient’s vital signs, are essential in the resuscitative care
of the hemorrhaging patient. These are key points that can be
easily overshadowed in the attempt to aggressively fluid-
resuscitate a patient who is in hemorrhagic shock.
Critical Care    October 2005 Vol 9 Suppl 5 Kauvar and WadeS5
The principles and practice of resuscitation are changing as
more is learned about the physiology of hemorrhagic shock
and fluid administration. One aspect in particular flux is the
area of resuscitation end-points. For nearly a century,
physicians have realized that excessive resuscitation may be
detrimental to hemostasis [55]. Current ATLS guidelines call
for the replacement of each milliliter of lost blood with three
times the amount of isotonic crystalloid, while giving careful
attention to the physiologic response of the patient. Attempts
to restore ‘normal’ vital signs in the patient with uncontrolled
hemorrhage can be detrimental, producing the conse-
quences of volume overload and rebleeding, leading to
coagulopathy and the bloody vicious cycle. A strategy of
‘hypotensive resuscitation’, whereby fluid is administered with
the end-point of a safe but subnormal blood pressure until
surgical control of bleeding can be achieved, has been
studied in various animal and limited human trials and
appears to be a promising way to mitigate some of the
problems incurred by more traditional resuscitative strategies
[56-62]. Hypotensive resuscitation is probably beneficial for
only a limited duration, however, and prompt attention to
hemorrhage control is vital.
In addition to changing perspectives on the end-points of
intravenous fluid resuscitation, the choice of fluid is under
investigation as well. There is experimental evidence that, in
addition to the detrimental effect of the large volumes
administered, the isotonic crystalloids themselves cause
undue immune activation and increase regulation of cellular
injury markers. These effects are seen with hypertonic and
colloid solutions as well [63-65]. These cellular events may
predispose patients to poor outcomes, but this has not been
directly studied. Various potential replacements for normal
saline and Ringer’s lactate have been studied, and some are
currently in use in various situations. These solutions include
hyperosmolar colloid and hypertonic electrolyte compounds.
Some, such as the 6% hydroxyethyl starches Hextend®
(BioTime, Inc., Emeryville, California, USA) and Hespan®
(BraunMedical, Inc., Irvine, California, USA) are approved for
use in volume expansion in the USA. These and others such
as RescueFlow® (BioPhausia AB, Stockholm, Sweden) and
HyperHES® (Vidal, Issy Les Moulineaux, France) are
approved and in use in Europe. Hypertonic solutions such as
7.5% saline, HyperHES®, RescueFlow®, and the combination
fluid hypertonic saline–dextran have been studied in human
resuscitation and found to be safe [66]. The evidence in
support of the use of these fluids is not universal, and no
study to date has demonstrated a clear positive effect on
outcome, and so the debate continues regarding these fluids
and their use [67-70].
The transfusion of blood and blood products is a cornerstone
of the resuscitation of the severely bleeding patient. ATLS
calls for the administration of packed RBCs along with
continued isotonic crystalloids if a patient does not respond
or responds only transiently to the initial 2 l crystalloid
infusion. Hemoglobin-based oxygen carriers are a promising
group of compounds that are undergoing study as potential
resuscitative fluids or as compounds to limit transfusion
[71,72]. Transfusion of blood products such as fresh frozen
plasma, cryoprecipitate, and platelet concentrate are used to
treat coagulopathy and prevent or interrupt the bloody vicious
cycle. Blood and blood product transfusions are discussed
further in other articles in this supplement.
Operative phase
The operative phase follows the initial resuscitative phase, but
fluid resuscitation often continues while the patient is in the
operating room. Although not all patients undergo an operation,
most severe hemorrhages require surgical intervention, and
approximately 50% of patients in hemorrhagic shock are
moved to the operating room from the emergency department
[17]. Efforts to control bleeding and repair damaged tissue
surgically are made, and in the critically ill patient an
abbreviated ‘damage control’ procedure is performed, whereby
life-threatening injuries are quickly addressed, the patient is
taken to the ICU for continued resuscitation and restoration of
physiology, and is then returned to the operating room at a later
time to complete the procedures [24]. Restoring physiology
involves attempts to interrupt the bloody vicious cycle through
aggressive rewarming, effective resuscitation, and correction of
acidosis. Resuscitation continues in a dynamic fashion with
responses to the rapidly changing physiologic status of the
patient. Even with aggressive approaches to the correction of
the hypothermia and acidosis commonly associated with the
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Table 1
Interventions to improve hemostasis in trauma care
Phase Details
Early, prehospital  Control overt hemorrhage
interventions Direct pressure
Pressure dressing
Tourniquet
Diagnose and treat occult hemorrhage
Stabilization of pelvis and long bone 
fractures
Keep patient warm
Resuscitative phase Warmed intravenous fluids
Hypotensive resuscitation prior to surgical 
control of hemorrhage
Appropriate transfusion of blood and 
blood products
Operative phase Surgical control of life-threatening 
hemorrhage
Damage control operations for critically ill 
patients
Appropriate transfusion of blood and 
blood products
Critical care phase Effective resuscitation
End-points of tissue perfusion
Physiologic support to prevent 
coagulopathyS6
coagulopathy of traumatic injury, once the bloody vicious cycle
has begun it is exceedingly difficult to salvage the patient
[41,44].
Critical care phase
The critical care phase in the care of the bleeding trauma
patient follows either the operative phase or is a continuation
of resuscitation in the ICU. Efforts to attain and preserve
normal physiology are initiated and continued, the patient is
closely monitored (often invasively), and support is provided
as needed as the patient recovers from injury. End-points and
goals for the resuscitation of severely injured patients are
undergoing constant reappraisal. Standard hemodynamic
parameters such as blood pressure and heart rate are no
longer regarded as the best measures of physiologic
derangement in the critically ill trauma patient. Shock is
defined as a state of decreased tissue perfusion, and values
that characterize this state more closely represent the status
of a patient in and recovering from shock. Examples of these
include measures of oxygen delivery, mixed venous oxygen
saturation, base deficit and lactate, end-tidal carbon dioxide,
gastric tonometry, and more direct measures of peripheral
tissue perfusion such as subcutaneous electrode oxygen and
carbon dioxide measurements and near infrared
spectroscopy. None of these measures is able to predict with
perfect reliability the outcome of a patient, but they are more
specific measures of physiologic status and research is
ongoing to improve them [73].
As the injured patient undergoes the physiologic changes
associated with injury and recovery, several complications
can arise. The most devastating of these are infections,
primarily sepsis, and MOF. These are the leading causes of
late traumatic fatality, and much of the ICU care administered
to critically ill patients aims at their prevention [13,15,16].
Vigilant attention to all major organ systems and an integrated
team approach to patient care involving specialist physicians,
nurses, and allied health providers are critical to the
achievement of good outcomes.
Traumatic hemorrhage therapy and outcome
Now that the scope of the problem of traumatic hemorrhage
has been defined and current management strategies
outlined, we explore the various ways in which the effect of
modern developments in trauma care, such as those
addressed in this supplement, can be measured. The control
of hemorrhage in severe trauma is a complicated issue that is
influenced by numerous factors, and likewise measuring
outcomes in these patients is not straightforward. The
remainder of this review discusses outcome measures that
should be part of the evaluation of any proposed hemorrhage
control therapy. Table 2 presents such measures.
Mortality
The most widely used and clinically significant trauma
outcome measure is mortality, and we have pointed out that
hemorrhage accounts for a large portion of deaths. Saving
lives is the ultimate goal of most clinical interventions, and to
this end the prospect of reducing mortality from hemorrhage
presents great potential benefit to the injured. Because of the
wide spectrum of traumatic injuries and their severities,
however, it has been difficult to show improvements in
mortality with most new interventions. We know of no
interventions for the control of bleeding or fluid resuscitation
that have been approved based on a reduction in mortality in
trauma patients.
Mortality in trauma patients occurs throughout the course of
treatment. Most deaths that occur early, within 48 hours from
injury, are the result of the severity of injuries sustained [13].
This pattern has resulted in the thought that such early
deaths are difficult to address and has led to a strong
emphasis on preventing later deaths from complications such
as sepsis and MOF. The predominance of acute traumatic
death from hemorrhage makes hemorrhage control an
important area of research if early traumatic deaths are to be
prevented.
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Table 2
Outcome measures for hemostatic interventions in trauma
Outcome measure Details
Mortality Overall
Early
Late
Complications Organ failure
Acute respiratory distress syndrome
Renal failure
Inotropes
Hyperbilirubinemia
Infection
Sepsis
Pneumonia
Coagulopathy
Continued bleeding
Transfusion requirement
Costs Inpatient care
Outpatient care
Rehabilitative care
Life and work years lost
Other Hospital days
Intensive care
Hospital
Ventilator
Laboratory tests
Prothrombin time
Partial thromboplastin time
Thromboelastography
Transfusion requirement
Packed red blood cells
Fresh frozen plasma
Platelets
CryoprecipitateS7
Complications
The trauma literature is replete with articles on the
development of complications during an injured patient’s
clinical course. The two most significant complications are
organ failure and infections because these are common
causes of late traumatic fatality [13,14,16,19]. Various
factors have been associated with the development of MOF,
including the presence of hypovolemic shock, advanced age,
severe injury, and blood transfusion. Therefore, this complica-
tion seems to be a reasonable marker for the overall condition
of the patient, given their injuries, and thus is an appropriate
intermediate outcome measure [18,19,22]. Serious infectious
complications such as sepsis and pneumonia are common in
the severely injured, especially those who have been in
shock, and so this is another reasonable outcome measure
for hemorrhage intervention [18].
Intensive care unit and hospital factors
Patients who suffer severe hemorrhage and shock are
typically critically ill, requiring urgent operation and ICU
admission [17]. Their critical care courses can be lengthy and
fraught with multiple complications as noted above. Length of
stay in the ICU and overall hospital days can be used as
global measures of the pace of an injured patient’s recovery.
Number of days spent on a ventilator may serve as an
indicator of the overall progress of the patient, as may the
development and course of any pulmonary complications
such as acute respiratory distress syndrome. The eventual
disposition of an injured patient may also be used as an
outcome measure, representing the overall progress of an
injured patient at the time of hospital discharge.
Patients are discharged home with or without outpatient
rehabilitation, or to the various levels of inpatient care. This
may take the form of long-term or short-term acute care for
those patients who remain significantly debilitated, or of acute
or chronic rehabilitation for those patients who are improving
but require ongoing therapy following hospital discharge.
Laboratory evaluation and transfusion
The requirements for RBC and blood product transfusions
have been associated with other trauma outcome measures
and are important indicators of the severity of hemorrhage
and coagulopathy as well as the effectiveness of
interventions to improve hemostasis. Reduction in RBC
transfusion requirement is a good indicator that a hemostatic
intervention is efficacious. Laboratory measures may be used
to assess more specifically the performance of techniques
used to minimize hemorrhage and especially to address
coagulopathy. Laboratory monitoring of traumatic
coagulopathy is important in order to address occult
hemorrhage in patients whose bleeding has been surgically
controlled. In addition to the commonly used prothrombin and
partial thromboplastin times, which have been demonstrated
to lack accuracy in hypothermic patients [74], thrombo-
elastography – used commonly in cardiac and transplant
surgery – is emerging as a potentially useful test in traumatic
coagulopathy [75].
Costs
The significant financial costs of trauma care are increasing
rapidly with improvements in critical care. Critically ill trauma
patients are living longer but with increased morbidity, both in
the acute and chronic phases of their care and illness. The
impact of any proposed intervention in these patients must be
weighed carefully against its cost. The patient’s prognosis for
recovery must be included in the consideration to use a
powerful but expensive new intervention. To adopt the use of
such methods and agents without consideration of their
potential effect on survival or the prevention of complications
will inevitably lead to inappropriate use in some cases and
increased cost for very little benefit.
Conclusion
Traumatic injury is an international problem, affecting all
nations and people from all walks of life. Hemorrhage is a
major contributor to the morbidity and mortality of injury, and
attaining and maintaining hemostasis is a key consideration in
trauma care. Modern trauma care practices have been
developed to expeditiously identify and efficiently treat
traumatic hemorrhage, but numerous factors can contribute
to severe traumatic hemorrhage and the development of
coagulopathy. These can be difficult to treat, and novel
methods of hemostasis have the potential to produce great
benefit in these cases.
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